BRIEF-Processa Pharmaceuticals Announces Pricing Of $5 Mln Public Offering Priced At-The-Market Under Nasdaq Rules

Reuters
28 Jan
BRIEF-Processa Pharmaceuticals Announces Pricing Of $5 Mln Public Offering Priced At-The-Market Under Nasdaq Rules

Jan 27 (Reuters) - Processa Pharmaceuticals Inc PCSA.O:

  • PROCESSA PHARMACEUTICALS ANNOUNCES PRICING OF $5 MILLION PUBLIC OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

  • PROCESSA PHARMACEUTICALS INC - PURCHASE PRICE PER SHARE $0.615 FOR INSTITUTIONAL INVESTORS, $0.7975 FOR CEO AND BOARD

Source text: ID:nGNX7qXyFC

Further company coverage: PCSA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10